SCHEMBL7802893

SCHEMBL7802893

CCCCn1c(=O)n(CCCCC(C)=O)c(=O)c2c1ncn2CCC

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 12/20 0.83
LMNA P02545 2/20 0.83
CYP1A2 P05177 2/20 0.83
NFKB1 P19838 2/20 0.83
ACHE P22303 2/20 0.83
PMP22 Q01453 2/20 0.83
ESR1 P03372 1/20 0.83
MAPT P10636 1/20 0.83
BLM P54132 1/20 0.83
PDE4B Q07343 11/20 0.74
PDE4C Q08493 11/20 0.74
PDE4D Q08499 11/20 0.74
ADORA2A P29274 4/20 0.74
ADORA2B P29275 3/20 0.74
RXFP1 Q9HBX9 2/20 0.61
MAPK1 P28482 1/20 0.61
TNF P01375 2/20 0.60
USP2 O75604 1/20 0.60
TSHR P16473 1/20 0.60
SMN1; SMN2 Q16637 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10873386 0.96 PDE4A (0.77) PDE4ALMNACYP1A2NFKB1ACHE
SCHEMBL7793096 0.96 PDE4A (0.84) PDE4ALMNACYP1A2NFKB1ACHE
SCHEMBL7793146 0.94 PDE4A (0.81) PDE4ALMNACYP1A2NFKB1ACHE
SCHEMBL7800770 0.94 PDE4A (0.76) PDE4ALMNACYP1A2NFKB1ACHE
SCHEMBL11456819 0.93 PDE4A (0.77) PDE4ALMNACYP1A2NFKB1ACHE
SCHEMBL9853391 0.92 PDE4A (0.88) PDE4ALMNACYP1A2NFKB1ACHE
SCHEMBL11395350 0.92 PDE4A (0.76) PDE4ALMNACYP1A2NFKB1ACHE
SCHEMBL7612452 0.91 PDE4A (0.79) PDE4ALMNACYP1A2NFKB1ACHE
SCHEMBL7802154 0.91 PDE4A (0.75) PDE4ALMNACYP1A2NFKB1ACHE
Propentofylline SCHEMBL74602 0.91 PDE4A (1.00) PDE4ALMNACYP1A2NFKB1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0811623-B1 Xanthine derivatives with end-aminated alkynol side chains HOECHST AG (DE) 2001-04-04 EP disclosed
US-5965555-A TREATMENT AND/OR PROPHYLAXIS OF CEREBROVASCULAR DISORDERS CHARACTERIZED BY DAMAGE CAUSED BY ISCHEMIA AND SUBSEQUENT NECROTIC DESTRUCTION OF NERVE CELLS(NEURONS) HOECHST AKTIENGESELLSCHAFT (DE) 1999-10-12 US disclosed
EP-0811623-A1 Xanthine derivatives with end-aminated alkynol side chains HOECHST AKTIENGESELLSCHAFT (DE) 1997-12-10 EP disclosed
US-4289776-A VASODILATORS, FIBRINOLYTIC HOECHST AKTIENGESELLSCHAFT (DE) 1981-09-15 US disclosed